Employee turnover is costly and can hurt productivity, but advances in data analytics are helping to identify specific leadership behaviors that cause workers to quit, Jon Christiansen, co-founder of Insights and Outcomes, writes for Harvard Business Review.
David Lazarus, a business columnist for the Los Angeles Times, last week wrote a column detailing his struggles quitting antidepressants, but his article—titled "Hi, I'm David. I'm a drug addict"—received backlash from some critics for conflating addiction and physical dependence.
A U.S. District Court judge on Monday blocked the bankruptcy sale of Hahnemann University Hospital's residency programs following an appeal by CMS, in today's bite-sized hospital and health industry news from Massachusetts, Pennsylvania, and Virginia.
Federal and state officials last week raided a plastic surgery office following accusations that a doctor at the clinic administered non-FDA-approved drugs to patients who purchased certain services through Groupon, adding to growing concerns that Groupon users might be more vulnerable to medical scams.
In an interview with HealthLeaders Media's Jennifer Thew, two nursing leaders at Northwell Health explain how establishing a "culture of inquiry" improved care delivery, patient outcomes, and nurse engagement at the system.
An FDA advisory panel this month recommended approval of an experimental treatment for peanut allergies, but writing in The Atlantic, James Hamblin questions whether the product is worth its likely $4,200 price tag—and flags research suggesting it may backfire for some patients.
